A share price of Agenus Inc [AGEN] is currently trading at $0.68, up 1.05%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The AGEN shares have gain 4.33% over the last week, with a monthly amount glided 16.32%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 15, February 2024, Ginkgo Bioworks and SaponiQx Awarded MCDC Contract to Discover and Manufacture Next-Generation Vaccine Adjuvants Using Generative Molecular Design. In a post published today on Yahoo Finance, The Defense Threat Reduction Agency’s (DTRA) Joint Science and Technology Office (JSTO) for the Chemical and Biological Defense (CBD) Program has awarded, through the Medical CBRN [Chemical, Biological, Radiological, and Nuclear] Defense Consortium (MCDC) requirement 22-05, “Adjuvant Activity to Vaccines Prototype,” a 5-year contract totaling up to $31 million including program options to the team of Ginkgo Bioworks, Inc. (NYSE: DNA) and SaponiQx, Inc. (a subsidiary of Agenus Inc., NASDAQ:AGEN) to discover and develop next-generation vaccine adjuvants. Partners in adjuvant discovery and development since 2021, Ginkgo, which is building the leading platform for cell programming and biosecurity, and SaponiQx, developing a visionary adjuvant development platform, will use a combination of high-throughput empirical and artificial intelligence/machine learning approaches, including Generative Molecular Design (GMD), to develop superior novel saponin-based adjuvants.
From an analyst’s perspective:
Agenus Inc [NASDAQ: AGEN] stock has seen the most recent analyst activity on June 06, 2023, when Robert W. Baird initiated its Outperform rating and assigned the stock a price target of $8. Previously, Robert W. Baird started tracking the stock with Outperform rating on June 06, 2023, and set its price target to $80. SMBC Nikko started tracking the stock assigning a Outperform rating and suggested a price target of $5 on September 28, 2022. H.C. Wainwright initiated its recommendation with a Buy and recommended $12 as its price target on December 16, 2021. In a note dated April 22, 2019, B. Riley FBR initiated an Buy rating.
Agenus Inc experienced fluctuations in its stock price throughout the past year between $0.53 and $2.13. Agenus Inc [NASDAQ: AGEN] shares were valued at $0.68 at the most recent close of the market.
Analyzing the AGEN fundamentals
Trailing Twelve Months sales for Agenus Inc [NASDAQ:AGEN] were 100.90M which represents 6.77% growth. Gross Profit Margin for this corporation currently stands at -0.03% with Operating Profit Margin at -0.22%, Pretax Profit Margin comes in at -0.24%, and Net Profit Margin reading is -0.51%. To continue investigating profitability, this company’s Return on Assets is posted at -1.53, Equity is -2.61 and Total Capital is -22.65. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-6.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.6614 points at the first support level, and at 0.6407 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.7114, and for the 2nd resistance point, it is at 0.7407.
Agenus Inc [AGEN] reported earnings per share of -$0.16 for its fiscal quarter that ended on 9/29/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.19/share, meaning a difference of $0.03 and a surprise factor of 15.80%. By comparison, the stated earnings for the previous quarter ended on 6/29/2023 were -$0.2 per share as compared to estimates of -$0.2 per share, a difference of $0 representing a surprise of 0.00%.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Agenus Inc [NASDAQ:AGEN] is 0.63. As well, the Quick Ratio is 0.63, while the Cash Ratio is 0.05. Considering the valuation of this stock, the price to sales ratio is 2.58.
Transactions by insiders
Recent insider trading involved ARMEN GARO H,, that happened on Feb 15 when 0.5 million shares were purchased. Director, WIINBERG ULF completed a deal on Nov 15 to buy 25000.0 shares. Meanwhile, 10% Owner AGENUS INC bought 429.0 shares on Oct 16.
